“Omalizumab Dose Step-Up and Treatment Response in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results from the OPTIMA Study” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S52. doi:10.25251/skin.2.supp.52.